Nigrostriatal function in humans studied with positron emission tomography

作者: W. R. W. Martin , M. R. Palmer , C. S. Patlak , D. B. Calne

DOI: 10.1002/ANA.410260407

关键词:

摘要: The dopamine depletion that is characteristic of Parkinson's disease has been hypothesized to result from the combination environmentally induced subclinical damage substantia nigra and age-related loss additional nigral neurons. Essential this hypothesis existence deteriorating function in nigrostriatal pathway with advancing age. present study was undertaken [18F]6-fluoro-L-dopa positron emission tomography determine vivo effects age on a series 10 asymptomatic subjects (age range, 22-80 years; mean, 49.8 years). A graphical approach used analysis multiple-time tracer-uptake data establish presence compartment unidirectional uptake calculate rate constant, K, for blood striatum during steady-state, an index functional integrity nerve endings. There significant linear relationship between K (r = 0.80, p less than 0.005) decrease 53.3% over range studied. These results demonstrate application transfer model provide confirmation impairment function.

参考文章(32)
LA Wade, R Katzman, Rat brain regional uptake and decarboxylation of L-DOPA following carotid injection American Journal of Physiology. ,vol. 228, pp. 352- 359 ,(1975) , 10.1152/AJPLEGACY.1975.228.2.352
Hornykiewicz O, Kish Sj, Biochemical pathophysiology of Parkinson's disease. Advances in Neurology. ,vol. 45, pp. 19- 34 ,(1987)
M.J. Adam, S. Jivan, Synthesis and purification of l-6-[18F]fluorodopa International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes. ,vol. 39, pp. 1203- 1206 ,(1988) , 10.1016/0883-2889(88)90100-1
G. Firnau, S. Sood, R. Chirakal, C. Nahmias, E. S. Garnett, Cerebral metabolism of 6-[18F]fluoro-L-3.4-dihydroxyphenylalanine in the primate Journal of Neurochemistry. ,vol. 48, pp. 1077- 1082 ,(1987) , 10.1111/J.1471-4159.1987.TB05629.X
Nobuhiro MIYAKOSHI, Minoru TANAKA, Hideyo SHINDO, Autoradiographic studies on distribution of L-3,4-dihydroxyphenylalanine (L-DOPA)-14C and L-5-hydroxytryptophan (L-5-HTP)-14C in the cat brain. The Japanese Journal of Pharmacology. ,vol. 30, pp. 795- 805 ,(1980) , 10.1254/JJP.30.795
H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, F. Seitelberger, Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations Journal of the Neurological Sciences. ,vol. 20, pp. 415- 455 ,(1973) , 10.1016/0022-510X(73)90175-5
K. L. Leenders, W. H. Poewe, A. J. Palmer, D. P. Brenton, R. S. J. Frackowiak, Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography. Annals of Neurology. ,vol. 20, pp. 258- 262 ,(1986) , 10.1002/ANA.410200212
Claude Nahmias, E.Stephen Garnett, Gunter Firnau, Anthony Lang, Striatal dopamine distribution in Parkinsonian patients during life Journal of the Neurological Sciences. ,vol. 69, pp. 223- 230 ,(1985) , 10.1016/0022-510X(85)90135-2
K L Leenders, A J Palmer, N Quinn, J C Clark, G Firnau, E S Garnett, C Nahmias, T Jones, C D Marsden, Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 49, pp. 853- 860 ,(1986) , 10.1136/JNNP.49.8.853